# Study of Subcutaneous Continuous Administration of Levodopa/Carbidopa Solution (ND0612) in Healthy Volunteers

> **NCT01486628** · PHASE1 · COMPLETED · sponsor: **NeuroDerm Ltd.** · enrollment: 36 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** ND0612
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01486628
- **Lead sponsor:** NeuroDerm Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04-30
- **Primary completion:** 2012-11-22
- **Final completion:** 2013-06-13
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2024-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01486628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01486628, "Study of Subcutaneous Continuous Administration of Levodopa/Carbidopa Solution (ND0612) in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01486628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*